Sermorelin
Sermorelin corresponds to the amidated 1–29 fragment of growth hormone-releasing hormone (GHRH). This N-terminal fragment retains the sequence associated with GHRH-receptor activity. This product is supplied as Sermorelin acetate.
Product Procurement
Research-use catalog items with clear ordering, product context, and documentation support.
Sermorelin — 10mg
$44.99
Product estimate
- NET VIAL CONTENT
- 10mg
- CATEGORY
- Peptides
- SKU
- ALS-SERM-10MG
In stock
Research Use Notice
For laboratory research use only. Not for human or animal use or consumption. Not for diagnostic, therapeutic, or veterinary use. Product documentation and certificates of analysis do not establish safety or suitability for these uses.
Product Intelligence
Sermorelin Compound Profile
GHRH(1–29) peptide research material associated with GHRH-receptor studies, supplied as Sermorelin acetate with 10mg net vial content.
10mg Net Vial Content
Each vial contains 10mg of Sermorelin.
GHRH Receptor / Peptide Structure–Activity Research
Sermorelin belongs to the GHRH-receptor agonist class. Research on GHRH(1–29) and related analogues examines how amino acid substitutions and peptide conformation influence activity in pituitary-cell assays. These sequence–activity studies provide a molecular context for GHRH-fragment research. (IUPHAR/BPS Guide to Pharmacology, Sermorelin; Cervini et al., 1998; PMID 9513600.)
- ClassGHRH-fragment peptide
- Chemical FormAcetate
- Net Vial Content10mg
- IdentifierPubChem CID 16132413 (Sermorelin peptide)
- CAS114466-38-5 (acetate)
Documentation
Verification & Documentation
Documentation is handled by product and lot. Use Standards to search for a matching record; if none appears, contact support with the product name, SKU, and lot number.